Disease Name |
ICD 11 |
Studied Tissue |
p-value |
Fold-Change |
Z-score |
Acute myelocytic leukaemia
|
2B33.1 |
Bone marrow |
1.06E-01
|
-8.38E-02
|
-4.21E-01 |
Alzheimer's disease
|
8A20 |
Entorhinal cortex |
4.75E-06
|
3.61E-01
|
5.90E-01 |
Asthma
|
CA23 |
Nasal and bronchial airway |
2.37E-02
|
1.10E-01
|
1.41E-01 |
Behcet's disease
|
4A62 |
Peripheral blood |
6.03E-01
|
7.03E-02
|
3.14E-01 |
Bipolar disorder
|
6A60-6A6Z |
Prefrontal cortex |
1.34E-01
|
1.19E-02
|
3.58E-02 |
Bladder cancer
|
2C94 |
Bladder tissue |
4.94E-01
|
-1.12E-01
|
-2.34E-01 |
Breast cancer
|
2C60-2C6Z |
Breast tissue |
1.33E-153
|
-1.08E+00
|
-3.34E+00 |
Colon cancer
|
2B90 |
Colon tissue |
1.38E-28
|
2.94E-01
|
1.09E+00 |
Diffuse large B-cell lymphoma
|
2A81 |
Tonsil tissue |
5.11E-01
|
-4.30E-02
|
-2.76E-01 |
Familial hypercholesterolemia
|
5C80.00 |
Peripheral blood |
3.87E-01
|
-7.34E-02
|
-3.42E-01 |
Gastric cancer
|
2B72 |
Gastric tissue |
4.34E-02
|
-1.22E+00
|
-2.55E+00 |
Glioblastopma
|
2A00.00 |
Nervous tissue |
7.55E-46
|
7.94E-01
|
1.04E+00 |
Head and neck cancer
|
2D42 |
Head and neck tissue |
1.06E-35
|
7.87E-01
|
1.97E+00 |
HIV-associated neurocognitive impairment
|
8A2Y-8A2Z |
White matter tissue |
1.26E-01
|
3.83E-01
|
7.31E-01 |
Idiopathic pulmonary fibrosis
|
CB03.4 |
Lung tissue |
5.57E-02
|
4.42E-01
|
1.12E+00 |
Interstitial cystitis
|
GC00.3 |
Bladder tissue |
3.39E-01
|
9.59E-02
|
2.84E-01 |
Ischemic stroke
|
8B11 |
Peripheral blood |
6.68E-03
|
7.15E-02
|
3.56E-01 |
Liver cancer
|
2C12.0 |
Liver tissue |
3.31E-02
|
-1.44E-01
|
-7.55E-01 |
Liver failure
|
DB99.7-DB99.8 |
Liver tissue |
1.39E-03
|
5.90E-01
|
2.18E+00 |
Lung cancer
|
2C25 |
Lung tissue |
3.62E-01
|
-7.59E-02
|
-1.97E-01 |
Lupus erythematosus
|
4A40 |
Whole blood |
1.02E-01
|
-1.75E-01
|
-3.07E-01 |
Major depressive disorder
|
6A70-6A7Z |
Hippocampus |
9.12E-01
|
-1.97E-02
|
-6.87E-02 |
Multiple myeloma
|
2A83.1 |
Bone marrow |
6.51E-04
|
-3.41E-01
|
-1.93E+00 |
Multiple myeloma
|
2A83.1 |
Peripheral blood |
2.62E-02
|
2.25E-01
|
1.33E+00 |
Multiple sclerosis
|
8A40 |
Plasmacytoid dendritic cells |
5.27E-01
|
-1.09E-01
|
-3.82E-01 |
Myelodysplastic syndrome
|
2A36-2A3Z |
Bone marrow |
5.34E-01
|
1.57E-02
|
1.26E-01 |
Myocardial infarction
|
BA41-BA50 |
Peripheral blood |
4.57E-02
|
3.42E-01
|
6.99E-01 |
Neuroectodermal tumour
|
2A00.11 |
Brain stem tissue |
4.78E-07
|
-8.33E-01
|
-3.33E+00 |
Non-alcoholic fatty liver disease
|
DB92 |
Liver tissue |
7.91E-01
|
-1.34E-02
|
-1.20E-01 |
Obesity related type 2 diabetes
|
5A11 |
Omental adipose tissue |
1.35E-01
|
2.36E-01
|
5.63E-01 |
Olive pollen allergy
|
CA08.00 |
Peripheral blood |
7.60E-01
|
3.55E-03
|
1.95E-02 |
Oral cancer
|
2B6E |
Oral tissue |
6.66E-06
|
4.66E-01
|
1.14E+00 |
Ovarian cancer
|
2C73 |
Ovarian tissue |
6.17E-04
|
-1.06E+00
|
-1.71E+00 |
Pancreatic cancer
|
2C10 |
Pancreas |
1.47E-01
|
4.43E-03
|
6.72E-03 |
Parkinson's disease
|
8A00.0 |
Substantia nigra tissue |
1.34E-01
|
6.30E-01
|
1.14E+00 |
Pituitary cancer
|
2D12 |
Pituitary tissue |
6.84E-02
|
-4.58E-01
|
-1.47E+00 |
Polycystic ovary syndrome
|
5A80.1 |
Vastus lateralis muscle |
2.68E-01
|
4.66E-02
|
3.87E-01 |
Pompe disease
|
5C51.3 |
Biceps muscle |
3.49E-04
|
2.01E+00
|
4.72E+00 |
Prostate cancer
|
2C82 |
Prostate |
1.15E-07
|
-9.49E-01
|
-1.45E+00 |
Psoriasis
|
EA90 |
Skin |
1.63E-05
|
-1.84E-01
|
-4.01E-01 |
Rectal cancer
|
2B92 |
Rectal colon tissue |
1.31E-04
|
4.85E-01
|
2.83E+00 |
Renal cancer
|
2C90-2C91 |
Kidney |
4.63E-04
|
-5.54E-01
|
-2.06E+00 |
Retinoblastoma
|
2D02.2 |
Uvea |
4.67E-06
|
9.59E-01
|
4.42E+00 |
Schizophrenia
|
6A20 |
Prefrontal cortex |
9.33E-02
|
9.44E-02
|
1.92E-01 |
Schizophrenia
|
6A20 |
Superior temporal cortex |
9.04E-01
|
4.89E-02
|
1.51E-01 |
Scleroderma
|
4A42.Z |
Whole blood |
8.08E-01
|
5.14E-02
|
2.51E-01 |
Seizure
|
8A60-8A6Z |
Whole blood |
8.01E-01
|
-1.22E-01
|
-5.38E-01 |
Sepsis with septic shock
|
1G41 |
Whole blood |
3.86E-01
|
3.76E-03
|
1.16E-02 |
Sickle cell disease
|
3A51.0-3A51.3 |
Peripheral blood |
4.74E-02
|
1.72E-01
|
9.89E-01 |
Simpson golabi behmel syndrome
|
LD2C |
Adipose tissue |
7.23E-01
|
4.54E-02
|
1.61E-01 |
Sjogren's syndrome
|
4A43.2 |
Salivary gland tissue |
3.12E-01
|
-1.29E-02
|
-1.91E-01 |
Skin cancer
|
2C30-2C3Z |
Skin |
1.33E-01
|
1.58E-02
|
3.90E-02 |
Thrombocythemia
|
3B63 |
Whole blood |
1.39E-03
|
1.40E-01
|
7.87E-01 |
Thrombocytopenia
|
3B64 |
Whole blood |
5.11E-01
|
9.78E-03
|
6.86E-02 |
Thyroid cancer
|
2D10 |
Thyroid |
7.03E-07
|
-3.32E-01
|
-7.94E-01 |
Tibial muscular dystrophy
|
8C75 |
Muscle tissue |
8.03E-02
|
2.08E-01
|
3.54E-01 |
Tuberous sclerosis complex
|
LD2D.2 |
Perituberal tissue |
7.25E-02
|
5.01E-01
|
1.20E+00 |
Type 2 diabetes
|
5A11 |
Liver tissue |
5.37E-01
|
-2.03E-02
|
-1.30E-01 |
Ureter cancer
|
2C92 |
Urothelium |
9.08E-01
|
-2.65E-02
|
-1.24E-01 |
Uterine cancer
|
2C78 |
Endometrium tissue |
1.92E-31
|
-8.16E-01
|
-1.58E+00 |
Vitiligo
|
ED63.0 |
Skin |
1.17E-01
|
-1.16E-01
|
-6.19E-01 |
------------------------------------------------------------------------------------ |
|
|
|
|
|